Used primarily as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of carbonic anhydrase inhibitors. Its structure supports the creation of bioactive molecules with potential applications in treating glaucoma, epilepsy, and certain types of tumors. The sulfamoyl and piperidine functional groups enhance binding affinity to enzyme active sites, making it valuable in medicinal chemistry for designing targeted therapies. Additionally, it serves as a building block in combinatorial chemistry for generating compound libraries used in drug discovery.